Growth momentum Recent funding and product expansion signal a growing need for scalable discovery intelligence solutions; target Drug Hunter for expansion partnerships, premium data access, and enterprise licensing to support wider institutional adoption.

New capabilities Launch of Molecule Search indicates increasing demand for advanced structure search and analytics; propose upsell of enhanced search analytics, integration with existing workflows, and premium feature bundles for R&D teams.

Global footprint Serving over 200 institutions worldwide creates opportunities for cross-sell across pharma, biotech, investors, and nonprofits; tailor partnerships that leverage multinational deployments and data localization needs.

Tech leverage Diverse tech stack (cloud, analytics, collaboration, and automation tools) suggests readiness for platform integrations; pitch APIs, data export, and workflow integrations to embed Drug Hunter into researchers’ daily tools.

Financial health Mid-sized revenue with seed funding indicates room for tiered enterprise offerings and subscription-based expansions; propose high-value, long-term licensing, training services, and professional services to deepen stickiness.